A Phase 1, Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of TAK-700 in Hormone Therapy-Resistant Prostate Cancer Subjects
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Orteronel (Primary) ; Prednisolone
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Takeda
- 28 Oct 2015 New trial record